{"title":"自身抗体和高甘油三酯血症","authors":"Huazhen Liu, Naishi Li","doi":"10.3760/CMA.J.ISSN.1674-635X.2019.06.011","DOIUrl":null,"url":null,"abstract":"Autoantibodies are related to occurrence of some types of severe hypertriglyceridemia. Researches showed that autoantibodies of lipoprotein lipase, glycosylphosphatidylinositol-anchored high-density lipoprotein binding protein 1 and apolipoprotein C-Ⅱ could induce hypertriglyceridemia. This review focused on hypertriglyceridemia induced by autoantibodies and its treatment. \n \n \nKey words: \nHypertriglyceridemia; Autoantibody; Glycosylphosphatidylinositol-anchored high-density lipoprotein binding protein 1; Lipoprotein lipase; Apolipoprotein C-Ⅱ","PeriodicalId":9877,"journal":{"name":"中华临床营养杂志","volume":"27 1","pages":"389-392"},"PeriodicalIF":0.0000,"publicationDate":"2019-12-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Autoantibodies and hypertriglyceridemia\",\"authors\":\"Huazhen Liu, Naishi Li\",\"doi\":\"10.3760/CMA.J.ISSN.1674-635X.2019.06.011\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Autoantibodies are related to occurrence of some types of severe hypertriglyceridemia. Researches showed that autoantibodies of lipoprotein lipase, glycosylphosphatidylinositol-anchored high-density lipoprotein binding protein 1 and apolipoprotein C-Ⅱ could induce hypertriglyceridemia. This review focused on hypertriglyceridemia induced by autoantibodies and its treatment. \\n \\n \\nKey words: \\nHypertriglyceridemia; Autoantibody; Glycosylphosphatidylinositol-anchored high-density lipoprotein binding protein 1; Lipoprotein lipase; Apolipoprotein C-Ⅱ\",\"PeriodicalId\":9877,\"journal\":{\"name\":\"中华临床营养杂志\",\"volume\":\"27 1\",\"pages\":\"389-392\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2019-12-30\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"中华临床营养杂志\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.3760/CMA.J.ISSN.1674-635X.2019.06.011\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q4\",\"JCRName\":\"Nursing\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"中华临床营养杂志","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.3760/CMA.J.ISSN.1674-635X.2019.06.011","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"Nursing","Score":null,"Total":0}
Autoantibodies are related to occurrence of some types of severe hypertriglyceridemia. Researches showed that autoantibodies of lipoprotein lipase, glycosylphosphatidylinositol-anchored high-density lipoprotein binding protein 1 and apolipoprotein C-Ⅱ could induce hypertriglyceridemia. This review focused on hypertriglyceridemia induced by autoantibodies and its treatment.
Key words:
Hypertriglyceridemia; Autoantibody; Glycosylphosphatidylinositol-anchored high-density lipoprotein binding protein 1; Lipoprotein lipase; Apolipoprotein C-Ⅱ
期刊介绍:
The Chinese Journal of Clinical Nutrition was founded in 1993. It is the first professional academic journal (bimonthly) in my country co-sponsored by the Chinese Medical Association and the Chinese Academy of Medical Sciences to disseminate information on clinical nutrition support, nutrient metabolism, the impact of nutrition support on outcomes and "cost-effectiveness", as well as translational medicine and nutrition research. It is also a professional journal of the Chinese Medical Association's Parenteral and Enteral Nutrition Branch.
The purpose of the Chinese Journal of Clinical Nutrition is to promote the rapid dissemination of knowledge on nutrient metabolism and the rational application of parenteral and enteral nutrition, focusing on the combination of multidisciplinary and multi-regional field investigations and clinical research. It mainly reports on nutritional risk screening related to the indications of parenteral and enteral nutrition support, "cost-effectiveness" research on nutritional drugs, consensus on clinical nutrition, guidelines, expert reviews, randomized controlled studies, cohort studies, glycoprotein and other nutrient metabolism research, systematic evaluation of clinical research, evidence-based case reports, special reviews, case reports and clinical experience exchanges, etc., and has a special column on new technologies related to the field of clinical nutrition and their clinical applications.